摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5-bromo-[1,2,4]triazolo[1,5-a]pyrazin-8-yl)-[4-(4-isopropyl-piperazin-1-yl)-phenyl]-amine | 959756-10-6

中文名称
——
中文别名
——
英文名称
(5-bromo-[1,2,4]triazolo[1,5-a]pyrazin-8-yl)-[4-(4-isopropyl-piperazin-1-yl)-phenyl]-amine
英文别名
(5-Bromo[1,2,4]triazolo[1,5-a]pyrazin-8-yl)-[4-(4-isopropylpiperazin-1-yl)-phenyl]amine;5-bromo-N-[4-(4-propan-2-ylpiperazin-1-yl)phenyl]-[1,2,4]triazolo[1,5-a]pyrazin-8-amine
(5-bromo-[1,2,4]triazolo[1,5-a]pyrazin-8-yl)-[4-(4-isopropyl-piperazin-1-yl)-phenyl]-amine化学式
CAS
959756-10-6
化学式
C18H22BrN7
mdl
——
分子量
416.324
InChiKey
ZVHRHXHOJPEZRC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    26
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    61.6
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    3-[8-(4-morpholin-4-yl-phenylamino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-benzo[b]thiophene-7-carboxylic acid amide 、 (5-bromo-[1,2,4]triazolo[1,5-a]pyrazin-8-yl)-[4-(4-isopropyl-piperazin-1-yl)-phenyl]-amine 反应 0.02h, 生成 3-{8-[4-(4-isopropylpiperazin-1-yl)phenylamino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl}benzo[b]thiophene-7-carboxylic acid amide
    参考文献:
    名称:
    Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
    摘要:
    本发明揭示了一种Novel [1.2.4]triazolo[1,5-a]pyrazine化合物,其化学式如下:这些化合物可以制备成药物组成物,并可用于哺乳动物包括人类的预防和治疗多种疾病,例如,但不限于疼痛、炎症等。
    公开号:
    US20080090818A1
  • 作为产物:
    描述:
    4-{8-[4-(4-methyl-piperazin-1-yl)-phenylamino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl}-thiophene-2-carboxylic acid amide 、 5,8-二溴-[1,2,4]噻唑并[1,5-a]吡嗪4-(4-异丙基哌嗪-1-基)苯胺N,N-二异丙基乙胺异丙醇 、 petroleum ether 、 乙醚 为溶剂, 反应 16.0h, 以The title compound is isolated after trituration with diethyl ether and petroleum ether as a grey solid (2.59 g, 87%)的产率得到(5-bromo-[1,2,4]triazolo[1,5-a]pyrazin-8-yl)-[4-(4-isopropyl-piperazin-1-yl)-phenyl]-amine
    参考文献:
    名称:
    Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
    摘要:
    本发明揭示了一种Novel [1.2.4]triazolo[1,5-a]pyrazine化合物,其化学式如下:这些化合物可以制备成药物组成物,并可用于哺乳动物包括人类的预防和治疗多种疾病,例如,但不限于疼痛、炎症等。
    公开号:
    US20080090818A1
点击查看最新优质反应信息

文献信息

  • Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
    申请人:Andrews Inglis Martin James
    公开号:US20080090818A1
    公开(公告)日:2008-04-17
    Novel [1.2.4]triazolo[1,5-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.
    本发明揭示了一种Novel [1.2.4]triazolo[1,5-a]pyrazine化合物,其化学式如下:这些化合物可以制备成药物组成物,并可用于哺乳动物包括人类的预防和治疗多种疾病,例如,但不限于疼痛、炎症等。
  • Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
    申请人:Galapagos NV
    公开号:US07915256B2
    公开(公告)日:2011-03-29
    Novel [1.2.4]triazolo[1,5-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.
    公开了一种Novel [1.2.4]三唑并[1,5-a]吡嗪化合物,其化学式如下所示:这些化合物可以制备成药物组合物,并可用于哺乳动物(包括人类)的预防和治疗多种疾病,例如疼痛、炎症等等。
  • TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES
    申请人:Andrews Martin James Inglis
    公开号:US20100298300A1
    公开(公告)日:2010-11-25
    Novel [1.2.4]triazolo[1,5-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.
    本发明披露了一种具有以下公式表示的[1.2.4]三唑并[1,5-a]吡嗪化合物:这些化合物可以制备为药物组合物,并可用于预防和治疗哺乳动物包括人类的各种疾病,包括但不限于疼痛,炎症等。
  • WO2007/138072
    申请人:——
    公开号:——
    公开(公告)日:——
  • US7501411B2
    申请人:——
    公开号:US7501411B2
    公开(公告)日:2009-03-10
查看更多